COMPARISON OF HPV DETECTION USING HC-II METHOD WITH PAP SMEAR SCREENING IN COMMERCIAL SEX WORKERS IN KEDIRI
DOI:
https://doi.org/10.24293/ijcpml.v24i3.1336Keywords:
, Commercial sex worker. HPV, hybrid capture-II, Pap smearAbstract
Female commercial sex workers are females that have multiple sexual partners and have high risk due to exposure to blood, semen, and vaginal discharge contaminated with microorganisms causing sexually transmitted disease such as infection caused by Human papillomavirus (HPV). This behavior creates a high susceptibility for commercial sex workers in obtaining HPV, which is the leading cause of cervical cancer. Cervical cancer is the most common cancer in females in Indonesia, which is why screening, especially for females with a high risk such as commercial sex workers, must be done. The purpose of this experiment was to compare the detection methods of HPV using Hybrid capture-II (HC-II) in order to find out high risks HPV types (type 16, 18, 31, 33, 35, 39,45, 51, 52, 56, 58, 59, and 68) by Pap smear done in commercial sex workers in Campurejo Kediri Public Health Center. This study was a descriptive observational experiment with a cross-sectional method. The samples of this experiment were 47 female commercial sex workers, whose detection of HPV using HC-II method was done at the Clinical Pathology Laboratory of the Dr. Soetomo Hospital Surabaya, where 32 samples showed positive results (68.1%) and were infected with high-risk HPV and 15 negative results (31.9%), from the Pap smear three samples (6.4%) showed dysplasia (Cervical Intraepithelial Neoplasia/CIN 1) and 44 samples (93.6%) showed normal smears with inflammation or infection in the cervix. Statistically showed a significant difference between the results of HC-II and Papsmear (p=0.000).
Downloads
References
Koentjoro.Tutur sarang pelacur, Yogyakarta, Tinta, 2004; 4-6.
Daili SF. Tinjauan penyakit menular seksual (PMS), Ed ke5., Jakarta, Badan Penerbit Fakultas Kedokteran Universitas Indonesia, 2013; 89-109.
Melville C. Sexual and reproductive health at a glance, 2015; 20-28.
Rasjidi I dan Sulistiyanto H. Vaksin human papillomavirus dan eradikasi kanker serviks, Jakarta, Sagung Seto, 2007; 5 – 10.
Rasjidi I. Deteksi dini dan pencegahan kanker pada wanita, Cetakan I., Jakarta, Sagung Seto, 2009; 100-127.
Savitri A, Larasati A, Utami EDR. Kupas tuntas kanker payudara, leher rahim dan rahim, Yogyakarta, Pustaka Baru Press, 2015; 31 – 40.
WHO. Cervical cancer screening in developing countries: Report of a WHO consultation, Geneva, ISBN 92 4 154572 0, 2002; x – xi.
Dwipoyono B. Metoda-metoda untuk mendeteksi adanya infeksi HPV. Indonesian Journal of Cancer, 2008; 2: 82 – 84.
Noor RI, Aryati, Hartono P. Genotipe HPV dan pola infeksinya terkait jenis histopatologi kanker leher rahim. Indonesian Journal of Clinical Pathology and Medical Laboratory, 2014; 21(1): 67-64.
Amalia L, Mengobati kanker serviks dan 32 jenis kanker lainnya. Cetakan I, Yogyakarta, Landscape, 2009; 15 – 22.
Collutrium. Statistik penderita kanker di Indonesia, Agustus 2016 oleh Collaboration of sosial, art and national meeting 2016. www.collutriumhimafarma.wordpress.com. Diakses tanggal 4 juni 2017-06-05
Andrijono, Indriatmi W, Sarsito AS, Siregar B, Mocthar B, dkk. Infeksi human papillomavirus, Jakarta, Badan Penerbit Fakultas Kedokteran Universitas Indonesia, 2013; 89-109.
Juanda D, Kesuma H. Pemeriksaan metode IVA (inspeksi visual asamasetat) untuk pencegahan kanker serviks. Jurnal kedokteran dan kesehatan, 2015; 2(2): 169-174.
Digene. Inc, Hybrid capture technology. 2016. Diaksesdarihttp://www.digene.com/customer/techsup/hcs_tech.htm.
Novel SS, Safitri R, Harijanto SH, Nuswantara S. Perbandingan beberapa metode molekuler dalam uji DNA HPV (human papillomavirus). Cermin Dunia Kedokteran, 2011; 38(5): 356 – 358.
Nalliah S, Karikalan B, Kademane K. Multifaceted usage of HPV related tests and products in the management of cervical cancer - a review. Asian Pacific Journal of Cancer Prevention, 2015; 16(6): 2145-2150. doi:http://dx.doi.org/10.7314/APJCP.
Retnowati D, Rauf S, Masadah R. Deteksi human papillomavirus pada wanita pekerja seks komersial sebagai penapisan lesi pra kanker serviks uteri. Majalah obstetric dan ginekologi Indonesia, 2006; 30(1): 25-29.
Castle PE, Lorinz AT, Lohnas IM, Scott DR, Glass AG, et al. Result of human papillomavirus DNA testing with hybrid capture-II assay are reproducible. J Clin Microbiol. 2002; 40(3):1088-1090.
Jia H, Wang X, Long Z and Li L. Human papillomavirus infection and cervical dysplasia in female sex workers in northeast china: An observational study. BMC Public Health, 2015; 15c695 DOI 10.1186/s12889-015-2066-x.
Brown B, Blass MM, Cabral A, Byraiah G, Giraldes CG, et al. Human papillomavirus prevalence, cervical abnormalities and risk factors among female sex workers in Lima Peru. Int J STD AIDS. 2012; 23(4): 242-247.
WHO. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human papillomavirus and related cancers. Summary Report Update. 3rd Ed., 2010; 60 - 70
Novel SS, Nuswantara S, Safitri R. Kanker serviks dan infeksi human pappilomavirus (HPV). 2010; 143-146.
Andrijono. Kanker serviks. Jakarta, Badan Penerbit Fakultas Kedokteran Universitas Indonesia, 2016; 34 - 35
Nindrea RD, Prevalensi dan faktor yang mempengaruhi lesi pra kanker serviks pada wanita. Journal Endurance 2017; 2(1): 53-61(Kopertis wilayah X).
Leung KM, Yeoh GPS, Cheung HN, Fong YF, Chan KW. Prevalence of abnormal Papanicolaou smears in female sex workers in Hongkong. Hong Kong Med J, 2013; 19(3): 203-205.
Ellenson LH, Pirog EC. The female genital tract chapter 22. In Robbins and Cotran pathologic basis of disease. 8th Ed., Editor Kumarab Basfausto Aster. Philadelphia, Saunders Elsevier, 2010; 1017-1024 [Accesed on Juni 4th,2017]
Saleh HS. Can visual inspection with acetic acid be used as an alternative to Pap smear in screening cervical cancer?. Middle East Fertility Society Journal, 2014; 19: 187-191[Accesed on Juni 4th, 2017].
